TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...
TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...
TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...
/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...
TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 No TCB008-related Adverse Events seen in any of the re-start...
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9, 2024 EDINBURGH, Scotland, Sept. 9, 2024 /PRNewswire/ -- TC BioPharm...
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 6, 2024 EDINBURGH, Scotland, Sept. 6, 2024 /PRNewswire/ -- TC BioPharm...
TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland, Sept. 5, 2024 EDINBURGH, Scotland, Sept. 5, 2024 /PRNewswire/ -- TC...
TCBP Announces Dosing of 5 New Patients in ACHIEVE PR Newswire EDINBURGH, Scotland, Sept. 3, 2024 5 New patients dosed, bringing total to 6 patients dosed in ACHIEVE at higher dose level5...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約